---
title: AXOlabs vs Scinai Immunotherapeutics Ltd.
slug_a: axolabs
slug_b: scinai-immunotherapeutics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/axolabs/scinai-immunotherapeutics
---

# AXOlabs vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing on this directory.

## AXOlabs

- Profile: [/companies/axolabs](/companies/axolabs)

AXOlabs — Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.

Services: 13. Modalities: 1. Indications: 0. Locations: 3. Certifications: 2. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- In Vitro Pharmacology
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Bioinformatics & Data Science
- Oligonucleotide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Oligonucleotide

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Scinai Immunotherapeutics Ltd.

- Profile: [/companies/scinai-immunotherapeutics](/companies/scinai-immunotherapeutics)

Scinai Immunotherapeutics Ltd. — Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.

Services: 6. Modalities: 1. Indications: 3. Locations: 2. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian